Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 37 citing articles:

Nanomedicine Combats Drug Resistance in Lung Cancer
Xiuli Zheng, Xiao-Hai Song, Guonian Zhu, et al.
Advanced Materials (2023) Vol. 36, Iss. 3
Closed Access | Times Cited: 35
Landscapes and mechanisms of CD8+ T cell exhaustion in gastrointestinal cancer
Jiatong Ding, Kangping Yang, Haonan Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Metabolic heterogeneity in tumor cells impacts immunology in lung squamous cell carcinoma
Qian Wang, Neng Sun, Chaoyang Zhang, et al.
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access
Cytokine-driven cancer immune evasion mechanisms
Enrique J. Arenas
International review of cell and molecular biology (2025)
Closed Access
Characterization of Immunosuppressive Myeloid Cells in Merkel Cell Carcinoma: Correlation with Resistance to PD-1 Pathway Blockade
Shira Tabachnick‐Cherny, Thomas H. Pulliam, Haroldo J. Rodriguez, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 6, pp. 1189-1199
Open Access | Times Cited: 12
Prognostic Value and Genome Signature of m6A/m5C Regulated Genes in Early-Stage Lung Adenocarcinoma
Long Tian, Yan Wang, Jie Tian, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6520-6520
Open Access | Times Cited: 11
Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma
Jie Xiong, Shu Cheng, Xiao Gao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee
Anne Monette, Sarah H. Warren, J. Carl Barrett, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 7, pp. e009427-e009427
Open Access | Times Cited: 4
BTLApromoter hypomethylation correlates with enhanced immune cell infiltration, favorable prognosis, and immunotherapy response in melanoma
Minglei Yang, Chenxi Zheng, Miao Yu, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e009841-e009841
Open Access
Predictable regulation of survival by intratumoral microbe-immune crosstalk in patients with lung adenocarcinoma
Shuo Shi, Yuwen Chu, Haiyan Liu, et al.
Microbial Cell (2024) Vol. 11, pp. 29-40
Open Access | Times Cited: 3
Landscape of targeted therapies for lung squamous cell carcinoma
Qiuxuan Chen, Xiao-Shuo Zheng, Weiting Cheng, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Dapagliflozin alleviates renal inflammation and protects against diabetic kidney diseases, both dependent and independent of blood glucose levels
Anxiang Cai, Jianxiao Shen, Xiaoqian Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
The application of Raman spectroscopy for the diagnosis and monitoring of lung tumors
Yuyang Miao, Lihong Wu, Junlian Qiang, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 2
Artificial Macrophage with Hierarchical Nanostructure for Biomimetic Reconstruction of Antitumor Immunity
Henan Zhao, Renyu Liu, Liqiang Wang, et al.
Nano-Micro Letters (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Cuproptosis-related molecular subtypes direct T cell exhaustion phenotypes and therapeutic strategies for patients with lung adenocarcinoma
Yi-Pan Zhu, Huiting Deng, Xiuyu Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Methods for assessment of the tumour microenvironment and immune interactions in non-small cell lung cancer. A narrative review
Kanishka Rangamuwa, Christian Aloe, Michael Christie, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
TSTA3 overexpression promotes malignant characteristics in LUSC by regulating LAMP2-mediated autophagy and tumor microenvironment
Yanlin Guo, Yanlong Hao, Liuyi Shen, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
CD57-positive CD8 + T cells define the response to anti-programmed cell death protein-1 immunotherapy in patients with advanced non-small cell lung cancer
Wenjia Sun, Fengqi Qiu, Jing Zheng, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 1
High-dimensional deconstruction of ovarian cancer at single-cell precision reveals HEBP2 that reshape the TIME and drive carboplatin resistance
Bikang Yang, Miao Dai
Translational Oncology (2024) Vol. 44, pp. 101917-101917
Open Access | Times Cited: 1
Exploring T-cell exhaustion features in Acute myocardial infarction for a Novel Diagnostic model and new therapeutic targets by bio-informatics and machine learning
Nake Jin, Jiacheng Rong, Xudong Chen, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Identification of cytokine-predominant immunosuppressive class and prognostic risk signatures in glioma
Ziyue Tian, Zhongyi Yang, Meng Jin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Identification of cytokine-predominant immunosuppressive class and prognostic risk signatures in glioma
Ziyue Tian, Zhongyi Yang, Meng Jin, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 14, pp. 13185-13200
Open Access | Times Cited: 2
Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model
Dalton McLean, Jennifer J. Meudt, Loren D. Lopez Rivera, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Roles of tissue-resident immune cells in immunotherapy of non-small cell lung cancer
Rui Tang, Haitao Wang, Mingxi Tang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
[Exploring the Role of PCDHGB4 in the Occurrence of Lung Squamous Cell Carcinoma Based on Bioinformatics Analysis].
Ruijiao Lu, Xieyidai Abuduhailili, Yuxia Li, et al.
PubMed (2024) Vol. 27, Iss. 3, pp. 199-215
Closed Access
Page 1 - Next Page

Scroll to top